138 related articles for article (PubMed ID: 28868839)
21. Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study.
Ghaffarzad A; Amani R; Mehrzad Sadaghiani M; Darabi M; Cheraghian B
Int J Fertil Steril; 2016; 10(1):29-35. PubMed ID: 27123197
[TBL] [Abstract][Full Text] [Related]
22. Effect of bee venom on IL-6, COX-2 and VEGF levels in polycystic ovarian syndrome induced in Wistar rats by estradiol valerate.
Karimzadeh L; Nabiuni M; Kouchesfehani HM; Adham H; Bagheri A; Sheikholeslami A
J Venom Anim Toxins Incl Trop Dis; 2013 Dec; 19(1):32. PubMed ID: 24330637
[TBL] [Abstract][Full Text] [Related]
23. The effect of hydroalcoholic extract of
Khani S; Abdollahi M; Khalaj A; Heidari H; Zohali S
Int J Reprod Biomed; 2021 Mar; 19(3):271-282. PubMed ID: 33842824
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
[TBL] [Abstract][Full Text] [Related]
25. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of isoflavone-aglycone fraction from soybean (
Alivandi Farkhad S; Khazali H
Gynecol Endocrinol; 2019 Dec; 35(12):1078-1083. PubMed ID: 31185755
[TBL] [Abstract][Full Text] [Related]
27. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
28. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
[TBL] [Abstract][Full Text] [Related]
29. Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome.
Farideh ZZ; Bagher M; Ashraf A; Akram A; Kazem M
J Reprod Infertil; 2010 Oct; 11(3):169-74. PubMed ID: 23926485
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome.
Xiang SK; Hua F; Tang Y; Jiang XH; Zhuang Q; Qian FJ
Int J Endocrinol; 2012; 2012():173281. PubMed ID: 22792101
[TBL] [Abstract][Full Text] [Related]
31. The effect of dapsone in testosterone enanthate-induced polycystic ovary syndrome in rat.
Shirooie S; Khaledi E; Dehpour AR; Noori T; Khazaei M; Sadeghi F; Sobarzo-Sánchez E
J Steroid Biochem Mol Biol; 2021 Nov; 214():105977. PubMed ID: 34428594
[TBL] [Abstract][Full Text] [Related]
32. [Effect of high-frequency electroacupuncture on lipid metabolism in obesity rats].
Wang SJ; Xu HZ; Xiao HL
Zhen Ci Yan Jiu; 2008 Jun; 33(3):154-8. PubMed ID: 18807715
[TBL] [Abstract][Full Text] [Related]
33. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of
Ghowsi M; Khazali H; Sisakhtnezhad S
Iran J Basic Med Sci; 2018 Feb; 21(2):165-174. PubMed ID: 29456813
[TBL] [Abstract][Full Text] [Related]
35. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
Rababa'h AM; Matani BR; Ababneh MA
Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
[TBL] [Abstract][Full Text] [Related]
36. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of fenofibrate for hepatic steatosis in rats after severe burn].
Huang Z; Meng C; Chen J; Chen Y; Chen Y; Zhou T; Yang C
Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):277-82. PubMed ID: 27188486
[TBL] [Abstract][Full Text] [Related]
38. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
39. Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome.
Bulut G; Kurdoglu Z; Dönmez YB; Kurdoglu M; Erten R
Int J Clin Exp Pathol; 2015; 8(8):8774-85. PubMed ID: 26464620
[TBL] [Abstract][Full Text] [Related]
40. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
